Evaluation of treatment for rectal neuroendocrine tumors sized under 20 mm in comparison with the WHO 2010 guidelines

Matsuhashi,Nobuhisa; Takahashi,Takao; Tomita,Hiroyuki; Araki,Hiroshi; Ibuka,Takashi; Tanaka,Kaori; Tanahashi,Toshiyuki; Matsui,Satoshi; Sasaki,Yoshiyuki; Tanaka,Yoshihiro; Okumura,Naoki; Yamaguchi,Kazuya; Osada,Shinji; Yoshida,Kazuhiro

doi:10.3892/mco.2017.1326

Evaluation of treatment for rectal neuroendocrine tumors sized under 20 mm in comparison with the WHO 2010 guidelines

Authors:
- Nobuhisa Matsuhashi
- Takao Takahashi
- Hiroyuki Tomita
- Hiroshi Araki
- Takashi Ibuka
- Kaori Tanaka
- Toshiyuki Tanahashi
- Satoshi Matsui
- Yoshiyuki Sasaki
- Yoshihiro Tanaka
- Naoki Okumura
- Kazuya Yamaguchi
- Shinji Osada
- Kazuhiro Yoshida
View Affiliations

Affiliations: Department of Surgical Oncology, Gifu University School of Medicine, Gifu 501‑1194, Japan, Department of Tumor Pathology, Gifu University School of Medicine, Gifu 501‑1194, Japan, Department of Gastroenterology, Gifu University School of Medicine, Gifu 501‑1194, Japan
Published online on: July 18, 2017 https://doi.org/10.3892/mco.2017.1326
Pages: 476-480

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Rectal neuroendocrine tumor (NET) is a relatively rare lesion of the gastrointestinal tract, but the prospective examination with colonofiberoscopy or endoscopic ultrasound has increased the frequency of its detection. It is often difficult to determine the optimal treatment for NETs sized <20 mm in the clinical setting. Other clinicopathological variables are not considered in the current guidelines and staging systems. Although the effects of lymphovascular invasion are not covered by the World Health Organization (WHO) 2010 guidelines or tumor‑node‑metastasis (TNM) staging system, this may be promising for the establishment of improved guidelines and staging systems, particularly for early‑stage colorectal carcinoids. The aim of the present study was to evaluate rectal NETs sized <20 mm in comparison with the WHO 2010 guidelines. Between January 2005 and December 2013, 40 consecutive patients [26 men and 14 women; median age, 59.3 years (range, 34‑81 years)] who underwent endoscopic resection of rectal NETs, and 12 patients undergoing surgical resection of rectal NETs, were enrolled in this retrospective study. The median tumor size was 7.4 mm (range, 3‑15 mm). The locations of the NET were the rectosigmoid colon (n=3), the upper rectum (n=13), and the lower rectum (n=25). The NETs were classified by size as 0‑5 (n=7), 6‑10 (n=29) and 11‑15 mm (n=4). The surgical procedures performed included low anterior resection plus esophagectomy (n=1), laparoscopic low anterior resection (n=7) and laparoscopic intersphincteric resection (n=4). Only 1 patient had lymph node metastasis (tumor sized 6‑10 mm, with lymphovascular invasion). NET recurrence was not detected in any of the patients. According to the WHO guidelines, the tumors were classified as grade (G)1 (n=8), G2 (n=3) and G1/G2 (n=1). The tumor in the patient with lymph node metastasis was G1. NETs sized <10 mm may be curatively treated by endoscopic resection. However, NETs with either lymphovascular invasion or sized >1 cm carry a risk for metastasis equivalent to that of adenocarcinomas. Therefore, it is mandatory to histologically examine lymphovascular invasion in specimens retrieved via endoscopic resection to determine the necessity for further radical surgery with regional lymph node dissection. The treatment of NETs sized <20 mm as presently defined in the WHO 2010 guidelines requires further evaluation.

View Figures

View References

1	Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T and Nagawa H: Japanese Society for Cancer of the Colon and Rectum: Prognosis and risk factors of metastasis in colorectal carcinoids: Results of a nationwide registry over 15 years. Gut. 56:863–868. 2007. View Article : Google Scholar : PubMed/NCBI
2	Konishi T, Watanabe T, Muto T, Kotake K and Nagawa H: Japanese Society for Cancer of the Colon and Rectum: Site distribution of gastrointestinal carcinoids differs between races. Gut. 55:1051–1052. 2006.PubMed/NCBI
3	Konishi T, Watanabe T, Nagawa H, Oya M, Ueno M, Kuroyanagi H, Fujimoto Y, Akiyoshi T, Yamaguchi T and Muto T: Treatment of colorectal carcinoids: A new paradigm. World J Gastrointest Surg. 2:153–156. 2010. View Article : Google Scholar : PubMed/NCBI
4	Rindi G, Arnold R and Bosman F: Nomenclature and classification of neuroendocrine neoplasms of the digestive systemBosman FT, Carneiro F and Hruban RH: WHO Classification of Tumours of the Digestive System. IARC Press; Lyon: 2010
5	Hamilton SR and Aaltonen LA: World Health Organization, International Agency for Research on Cancer. Pathology and genetics of tumours of the digestive system. IARC Press; Lyon: pp. 105–111. 2000
6	Pelosi G, Bresaola E, Bogina G, Pasini F, Rodella S, Castelli P, Iacono C, Serio G and Zamboni G: Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol. 27:1124–1134. 1996. View Article : Google Scholar : PubMed/NCBI
7	Vilar E, Salazar R, Pérez-Garcia J, Cortes J, Oberg K and Tabernero J: Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. Endocr Relat Cancer. 14:221–232. 2007. View Article : Google Scholar : PubMed/NCBI
8	Klöppel G, Perren A and Heitz PU: The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification. Ann N Y Acad Sci. 1014:13–27. 2004. View Article : Google Scholar : PubMed/NCBI
9	Modlin IM, Kidd M, Latich I, Zikusoka MN and Shapiro MD: Current status of gastrointestinal carcinoids. Gastroenterology. 128:1717–1751. 2005. View Article : Google Scholar : PubMed/NCBI
10	Ito T, Tanaka M, Sasano H, Osamura YR, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, et al: Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors. J Gastroenterol. 42:497–500. 2007. View Article : Google Scholar : PubMed/NCBI
11	Soga J: Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases. J Exp Clin Cancer Res. 22:349–363. 2003.PubMed/NCBI
12	Soga J: Carcinids and their variant endocrinomas. An analysis of 11842 reported cases. J Exp Clin Cancer Res. 22:517–530. 2003.PubMed/NCBI
13	Soga J: Carcinoids of the rectum: An evaluation of 1271 reported cases. Surg Today. 27:112–119. 1997. View Article : Google Scholar : PubMed/NCBI
14	Soga J: Gastric carcinoids: A statistical evaluation of 1,094 cases collected from the literature. Surg Today. 27:892–901. 1997. View Article : Google Scholar : PubMed/NCBI
15	Soga J: Carcinoids of the small intestine: A statistical evaluation of 1102 cases collected from the literature. J Exp Clin Cancer Res. 16:353–363. 1997.PubMed/NCBI
16	Fahy BN, Tang LH, Klimstra D, Wong WD, Guillem JG, Paty PB, Temple LK, Shia J and Weiser MR: Carcinoid of the rectum risk stratification (CaRRS): A strategy for preoperative outcome assessment. Ann Surg Oncol. 14:396–404. 2007. View Article : Google Scholar : PubMed/NCBI
17	Fahy BN, Tang LH, Klimstra D, Wong WD, Guillem JG, Paty PB, Temple LK, Shia J and Weiser MR: Carcinoid of the rectum risk stratification (CaRRs): A strategy for preoperative outcome assessment. Ann Surg Oncol. 14:1735–1743. 2007. View Article : Google Scholar : PubMed/NCBI
18	Tanaka S, Oka S, Kaneko I, Hirata M, Mouri R, Kanao H, Yoshida S and Chayama K: Endoscopic submucosal dissection for colorectal neoplasia: Possibility of standardization. Gastrointest Endosc. 66:100–107. 2007. View Article : Google Scholar : PubMed/NCBI
19	Sakata H, Iwakiri R, Ootani A, Tsunada S, Ogata S, Ootani H, Shimoda R, Yamaguchi K, Sakata Y, Amemori S, et al: A pilot randomized control study to evaluate endoscopic resection using a ligation device for rectal carcinoid tumors. World J Gastroenterol. 12:4026–4028. 2006. View Article : Google Scholar : PubMed/NCBI
20	Nagai T, Torishima R, Nakashima H, Ookawara H, Uchida A, Kai S, Sato R, Murakami K and Fujioka T: Saline-assisted endoscopic resection of rectal carcinoids: Cap aspiration method versus simple snare resection. Endoscopy. 36:202–205. 2004. View Article : Google Scholar : PubMed/NCBI
21	Hasegawa T, Matsuno Y, Shimoda T and Hirohashi S: Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol. 33:669–676. 2002. View Article : Google Scholar : PubMed/NCBI
22	Yamaguchi T, Fujimori1 T, Tomita S, Ichikawa K, Mitomi H, Ohno K, Shida Y and Kato H: Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence. Diagn Pathol. 8:652013. View Article : Google Scholar : PubMed/NCBI
23	Mani S, Modlin IM, Ballantyne G, Ahlman H and West B: Carcinoids of the rectum. J Am Coll Surg. 179:231–248. 1994.PubMed/NCBI
24	Fujimoto Y, Oya M, Kuroyanagi H, Ueno M, Akiyoshi T, Yamaguchi T and Muto T: Lymph-node metastases in rectal carcinoids. Langenbecks Arch Surg. 395:139–142. 2010. View Article : Google Scholar : PubMed/NCBI